| 1 |
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al |
1:18-cv-01673 |
D.Del. |
|
|
|
|
| 2 |
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-05405 |
S.D.N.Y. |
|
|
|
|
| 3 |
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-05405 |
S.D.N.Y. |
|
|
|
|
| 4 |
Allergan, Inc. v. Taro Pharmaceutical Industries Ltd. |
1:17-cv-00663 |
D.Del. |
|
|
|
|
| 5 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 6 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 7 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 8 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:17-cv-00544 |
D.N.J. |
|
|
|
|
| 9 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:17-cv-00544 |
D.N.J. |
|
|
|
|
| 10 |
ApoPharma Inc. et al v. Taro Pharmaceutical Industries, Ltd. et al |
2:16-cv-00528 |
E.D.Tex. |
|
|
|
|
| 11 |
ApoPharma Inc. et al v. Taro Pharmaceutical Industries, Ltd. et al |
2:16-cv-00528 |
E.D.Tex. |
|
|
|
|
| 12 |
Merz Pharmaceuticals, LLC et al v. Taro Pharmaceuticals U.S.A., Inc. et al |
1:15-cv-10168 |
S.D.N.Y. |
|
|
|
|
| 13 |
Merz Pharmaceuticals, LLC et al v. Taro Pharmaceuticals U.S.A., Inc. et al |
1:15-cv-10168 |
S.D.N.Y. |
|
|
|
|
| 14 |
Salix Pharmaceuticals, Inc et al v. Taro Pharmaceutical U.S.A., Inc. et al |
1:15-cv-07980 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 15 |
Salix Pharmaceuticals, Inc et al v. Taro Pharmaceutical U.S.A., Inc. et al |
1:15-cv-07980 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 16 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 17 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 18 |
HORIZON PHARMA IRELAND LIMITED et al v.TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-06135 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 19 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 20 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 21 |
HORIZON PHARMA IRELAND LIMITED et al v. TARO PHARMACEUTICALS USA, INC. et al |
1:15-cv-05021 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 22 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:14-cv-05079 |
D.N.J. |
|
|
|
|
| 23 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al |
2:14-cv-05079 |
D.N.J. |
|
|
|
|
| 24 |
Medicis Pharmaceutical Corporation v. Taro Pharmaceutical U.S.A., Inc. et al |
1:10-cv-03549 |
S.D.N.Y. |
|
|
|
|